Skip to main content

and
  1. Article

    Open Access

    Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination

    Infection is the most common cause of mortality early in life, yet the broad potential of immunization is not fully realized in this vulnerable population. Most vaccines are administered during infancy and chi...

    David J. Dowling, Soumik Barman, Alyson J. Smith, Francesco Borriello in Scientific Reports (2022)